395 related articles for article (PubMed ID: 16244361)
1. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.
Ball LE; Berkaw MN; Buse MG
Mol Cell Proteomics; 2006 Feb; 5(2):313-23. PubMed ID: 16244361
[TBL] [Abstract][Full Text] [Related]
2. O-linked N-acetylglucosamine modification of insulin receptor substrate-1 occurs in close proximity to multiple SH2 domain binding motifs.
Klein AL; Berkaw MN; Buse MG; Ball LE
Mol Cell Proteomics; 2009 Dec; 8(12):2733-45. PubMed ID: 19671924
[TBL] [Abstract][Full Text] [Related]
3. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
5. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of the murine estrogen receptor-alpha.
Cheng X; Hart GW
J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):147-58. PubMed ID: 11226831
[TBL] [Abstract][Full Text] [Related]
7. Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.
Luo M; Reyna S; Wang L; Yi Z; Carroll C; Dong LQ; Langlais P; Weintraub ST; Mandarino LJ
Endocrinology; 2005 Oct; 146(10):4410-6. PubMed ID: 16020478
[TBL] [Abstract][Full Text] [Related]
8. Identification of O-GlcNAc sites on proteins.
Whelan SA; Hart GW
Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
[TBL] [Abstract][Full Text] [Related]
9. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
[TBL] [Abstract][Full Text] [Related]
10. Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody.
Yuzwa SA; Yadav AK; Skorobogatko Y; Clark T; Vosseller K; Vocadlo DJ
Amino Acids; 2011 Mar; 40(3):857-68. PubMed ID: 20706749
[TBL] [Abstract][Full Text] [Related]
11. Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952.
Greis KD; Gibson W; Hart GW
J Virol; 1994 Dec; 68(12):8339-49. PubMed ID: 7966627
[TBL] [Abstract][Full Text] [Related]
12. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
[TBL] [Abstract][Full Text] [Related]
14. O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.
Vosseller K; Trinidad JC; Chalkley RJ; Specht CG; Thalhammer A; Lynn AJ; Snedecor JO; Guan S; Medzihradszky KF; Maltby DA; Schoepfer R; Burlingame AL
Mol Cell Proteomics; 2006 May; 5(5):923-34. PubMed ID: 16452088
[TBL] [Abstract][Full Text] [Related]
15. Discovery of O-GlcNAc-modified proteins in published large-scale proteome data.
Hahne H; Gholami AM; Kuster B
Mol Cell Proteomics; 2012 Oct; 11(10):843-50. PubMed ID: 22661428
[TBL] [Abstract][Full Text] [Related]
16. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry.
Greis KD; Hayes BK; Comer FI; Kirk M; Barnes S; Lowary TL; Hart GW
Anal Biochem; 1996 Feb; 234(1):38-49. PubMed ID: 8742080
[TBL] [Abstract][Full Text] [Related]
17.
Liu L; Li L; Ma C; Shi Y; Liu C; Xiao Z; Zhang Y; Tian F; Gao Y; Zhang J; Ying W; Wang PG; Zhang L
J Biol Chem; 2019 Nov; 294(45):16620-16633. PubMed ID: 31527085
[No Abstract] [Full Text] [Related]
18. Identification of major ERK-related phosphorylation sites in Gab1.
Lehr S; Kotzka J; Avci H; Sickmann A; Meyer HE; Herkner A; Muller-Wieland D
Biochemistry; 2004 Sep; 43(38):12133-40. PubMed ID: 15379552
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute to insulin resistance.
Kim JA; Yeh DC; Ver M; Li Y; Carranza A; Conrads TP; Veenstra TD; Harrington MA; Quon MJ
J Biol Chem; 2005 Jun; 280(24):23173-83. PubMed ID: 15849359
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function.
Paz K; Liu YF; Shorer H; Hemi R; LeRoith D; Quan M; Kanety H; Seger R; Zick Y
J Biol Chem; 1999 Oct; 274(40):28816-22. PubMed ID: 10497255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
